Crypto · IPO · Market Intelligence

Clear Signals for Market Momentum

Track IPOs, private companies, and crypto-related market movements in one modern intelligence platform.

Explore Data

sagi habasov

1156 POSTS

Exclusive articles:

SKN | Proem Acquisition I Files for $130 Million IPO, Aiming to Capture Global Tech Growth

Proem Acquisition I, a blank check company led by senior executives from Proem Asset Management, has filed with the SEC for a $130 million...

SKN | Iron Horse Acquisition II Prices $200 Million IPO as Media and Entertainment SPACs Re-Enter Focus

Iron Horse Acquisition II has officially priced its initial public offering, raising $200 million as investor interest cautiously returns to sector-focused SPACs. The deal...

SKN | General Mills Earnings Reinforce Defensive Appeal as Revenue Pressures Persist

General Mills’ latest earnings update highlights the company’s continued ability to generate stable profits even as revenue growth remains under pressure. The packaged food...

SKN | SPAC One Universe Acquisition files for a $60 million IPO, led by Chinese executives

One Universe Acquisition Corp., a blank-check company led by a team of Chinese executives, has filed to raise 60 million dollars in an initial...

SKN | SPAC Crane Harbor Acquisition II Prices Upsized $300 Million IPO, Targeting Tech, Real Assets, and Energy

Crane Harbor Acquisition II has priced an upsized $300 million initial public offering, underscoring renewed investor appetite for select special purpose acquisition companies despite...

Breaking

SKN | American Century Investments Launches Emerging Markets Insights ETF on Nasdaq

Key Points: American Century Investments has launched the Emerging...

SKN | ETF Launches and Hilton’s Nasdaq Transfer Shape November 5 Listings

Key Takeaways: The November 5 IPO calendar listed five...

SKN | American Ventures Acquisition I Cuts Proposed IPO Size by 25% to $75 Million

American Ventures Acquisition I, a blank check company targeting...

SKN | Rezera Sets Terms for $200 Million IPO as GSK Signals Up to $25 Million Investment

Rezera, a clinical-stage biotechnology company developing oral NLRP3 inhibitors...
spot_imgspot_img